Injecting Wegovy in the Upper Arm: What the Evidence Says

What clinical guidance says about the upper arm as an injection site

Wegovy's UK licence and the accompanying Summary of Product Characteristics (held on the electronic Medicines Compendium) confirm subcutaneous injection into the outer upper arm as an approved site, equivalent to the abdomen and thigh. This is not a matter of preference left undefined; it was tested during the semaglutide clinical development programme and the pharmacokinetic profile across sites was found to be comparable.

The STEP 1 trial, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. That result was achieved across a population using all three permitted sites. There is no subgroup evidence to suggest one site outperforms another on weight outcomes, the choice comes down to comfort, practicality and rotation discipline.

A common assumption is that the upper arm delivers the medicine faster or more intensely than the abdomen. It does not. Subcutaneous absorption is governed by tissue depth and blood flow at the injection site, and for a once-weekly medicine like semaglutide those differences are clinically negligible across the three approved locations. You can read the NHS medicines page for semaglutide for a patient-level summary of how the treatment is used.

Finding the right spot on the upper arm, and why it matters

The target is the lateral (outer) aspect of the upper arm, roughly halfway between the shoulder and elbow. This area has enough subcutaneous fat for the needle to reach the correct tissue layer in most people. The inner arm and the shoulder cap (deltoid muscle) are not appropriate targets, muscle tissue absorbs medicines differently and can make injections more uncomfortable.

Pinching a fold of skin before injecting helps ensure the needle stays in the subcutaneous layer rather than going intramuscular, particularly for people with leaner arms. A 45-degree angle may be more comfortable than a straight 90-degree approach if you have less subcutaneous tissue in the area, though your prescriber or the Patient Information Leaflet can guide you on the exact technique for the specific pen you are using.

Self-injection into the upper arm is achievable but does require some flexibility or a stable surface. Many people find it easier with a mirror, or ask someone they trust to administer it. If the upper arm is consistently difficult to reach safely on your own, the abdomen or thigh are equally valid alternatives, there is no clinical ranking among the three sites. For more on using the back of the arm as a Wegovy injection site, including common questions about comfort and positioning, that page covers the topic in detail.

Site rotation and skin health over time

Rotating injection sites is not optional advice, it is a clinical recommendation. Injecting repeatedly into the same small area causes lipohypertrophy, a localised thickening of fatty tissue that can reduce absorption and lead to unpredictable dosing. If you want a full overview of using the Wegovy arm site as part of your rotation, including how to vary spots within the outer arm on successive weeks, that page covers the approach in detail.

Mild reactions at the injection site (brief redness, a small raised area, transient tenderness) are common after any subcutaneous injection and usually settle within a day or two. The NHS notes these among the typical injection-site responses for semaglutide. If you notice a reaction that is spreading, lasting more than a few days, or accompanied by significant pain, let your prescriber know. For anyone who has experienced arm soreness after a Wegovy injection, there is specific guidance on what is normal and when to seek advice.

One detail worth knowing: the pen should be at room temperature before you inject. A cold pen straight from the fridge is more likely to sting and can increase injection-site discomfort. The exact room-temperature window is specified in your Patient Information Leaflet, always check there rather than relying on general estimates. If your pen has felt warmer than expected during storage or transit, this page on Wegovy temperature excursions explains what to check and when to contact your prescriber.

Practical considerations and when to ask for support

The upper arm works well as part of a rotation plan, but it is worth being honest with yourself about whether you can reach it consistently and safely. Awkward technique, rushing, or strain from an uncomfortable angle all increase the chance of a poor injection, and a missed or poorly administered dose is worth avoiding on a once-weekly medicine.

If you are considering the cost of ongoing private treatment, a guide to Wegovy pricing in the UK covers what private prescriptions typically include and how to compare providers fairly. Wegovy is a prescription-only medicine and must always be obtained through a regulated pharmacy following clinical assessment; the GPhC pharmacy register lets you verify any online pharmacy before using them.

Questions about injection sites, technique or how your treatment is going are exactly the kind of thing a prescriber should hear. If you are thinking about starting Wegovy and want to talk through whether it is clinically appropriate for you, our prescribers are available seven days a week. Speak to our prescribers through the free consultation on our treatment page, there is no obligation, and the clinical review is thorough.